KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
申请人:Amgen Inc.
公开号:US20190374542A1
公开(公告)日:2019-12-12
Provided herein are KRAS G12C inhibitors, such as
composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.